SCHEMBL241283

SCHEMBL241283

CC(=O)OC1CC(C)(C)N([O])C(C)(C)C1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
TSHR P16473 2/20 0.50
ALDH1A1 P00352 1/20 0.48
ESR1 P03372 1/20 0.48
HSD17B10 Q99714 1/20 0.48
GAA P10253 3/20 0.39
MEN1 O00255 2/20 0.39
CHRM2 P08172 5/20 0.37
CHRM1 P11229 3/20 0.37
CHRM4 P08173 2/20 0.37
CHRM5 P08912 2/20 0.37
CHRM3 P20309 2/20 0.37
HTT P42858 1/20 0.36
CYP2D6 P10635 1/20 0.32
POLB P06746 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL241284 0.83 KMT2A (0.50) KMT2ATSHRALDH1A1ESR1HSD17B10
SCHEMBL985161 0.83 TSHR (0.50) KMT2ATSHRALDH1A1ESR1HSD17B10
SCHEMBL4734071 0.82 ALDH1A1 (0.50) KMT2ATSHRALDH1A1ESR1HSD17B10
SCHEMBL313673 0.82 KMT2A (0.49) KMT2ATSHRALDH1A1ESR1HSD17B10
SCHEMBL10717139 0.82 KMT2A (0.49) KMT2ATSHRALDH1A1ESR1HSD17B10
SCHEMBL1954401 0.81 TSHR (0.39) KMT2ATSHRALDH1A1ESR1HSD17B10
SCHEMBL1138567 0.80 KMT2A (0.63) KMT2ATSHRALDH1A1ESR1HSD17B10
SCHEMBL4802358 0.80 KMT2A (0.48) KMT2ATSHRALDH1A1ESR1HSD17B10
SCHEMBL5573455 0.80 KMT2A (0.55) KMT2ATSHRALDH1A1ESR1HSD17B10
Acetic Acid SCHEMBL13732260 0.80 KMT2A (0.51) KMT2ATSHRALDH1A1ESR1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 723 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312767-A1 SYNERGISTIC ANTIFOULANT COMPOSITIONS AND METHODS OF USING THE SAME ECOLAB USA INC. (US) 2023-10-05 US claimed
WO-2023192840-A1 SYNERGISTIC ANTIFOULANT COMPOSITIONS AND METHODS OF USING THE SAME ECOLAB USA INC. (US) 2023-10-05 WO claimed
CN-114350281-A Cross-linkable POE composition and application thereof, cross-linked POE film and preparation method and application thereof 国家能源投资集团有限责任公司 2022-04-15 CN claimed
CN-114044965-A Polyethylene foam material and preparation method thereof 江南大学 2022-02-15 CN claimed
CN-109641865-B Process for producing glycerate 花王株式会社 2021-11-26 CN claimed
EP-2981560-B1 CURING OF LIQUID THERMOSETTING RESINS REICHHOLD LLC 2 (US) 2021-10-13 EP claimed
CN-113150419-A Crosslinkable polyethylene composition, preparation method thereof and rotational molding product 国家能源投资集团有限责任公司 2021-07-23 CN claimed
EP-3713909-B1 METHOD FOR PRODUCING VINYL ACETATE WACKER CHEMIE AG (DE) 2021-05-26 EP claimed
CN-108368033-B Method for preparing trifloxystrobin GSP作物科学有限公司 2021-05-04 CN claimed
US-10947178-B2 Method for producing vinyl acetate WACKER CHEMIE AG (DE) 2021-03-16 US claimed
WO-2002010100-A2 RECYCLE OF NITROXYL-CONTAINING STREAMS AT LOW TEMPERATURE UNIROYAL CHEMICAL COMPANY, INC. (US) 2002-02-07 WO claimed
EP-1149846-A1 Oxidation of polysaccharides with nitroxyls SCA Hygiene Products Zeist B.V. (NL) 2001-10-31 EP claimed
US-20010034442-A1 Oxidation of polysaccharides with nitroxyls NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWENTENSCHAPPELIJK ONDERZOEK TNO (NL) 2001-10-25 US claimed
WO-2001040404-A1 COMPOSITION AND METHOD FOR INHIBITING POLYMERIZATION AND POLYMER GROWTH UNIROYAL CHEMICAL COMPANY, INC. (US) 2001-06-07 WO claimed
EP-1065197-A1 Process for preparing (meth)acrylic acid ROHM AND HAAS COMPANY (US) 2001-01-03 EP claimed
US-6121451-A Intermediates and process for the manufacture of camptothecin derivatives (CPT-11) and related compounds PHARMACIA & UPJOHN COMPANY (US) 2000-09-19 US claimed
EP-0835257-A1 NOVEL INTERMEDIATES AND PROCESS FOR THE MANUFACTURE OF CAMPTOTHECIN DERIVATIVES (CPT-11) AND RELATED COMPOUNDS PHARMACIA & UPJOHN COMPANY (US) 1998-04-15 EP claimed
US-5728872-A POLYMERIZATION INHIBITION WITH A NITROXYL RADICAL AND A DIHETERO-SUBSTITUTED BENZENE COMPOUND HAVING AT LEAST ONE TRANSFERABLE HYDROGEN ECOLAB USA INC. 1998-03-17 US claimed
EP-0765856-A1 Stabilized acrylic acid compositions Riemenschneider, Lutz (DE) 1997-04-02 EP claimed
WO-1996031513-A1 NOVEL INTERMEDIATES AND PROCESS FOR THE MANUFACTURE OF CAMPTOTHECIN DERIVATIVES (CPT-11) AND RELATED COMPOUNDS PHARMACIA & UPJOHN COMPANY (US) 1996-10-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312767-A1 SYNERGISTIC ANTIFOULANT COMPOSITIONS AND METHODS OF USING THE SAME MMAB, ALOX5, MTR KMT2A 3774/4885TSHR 4623/4885ALDH1A1 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.